Clinical Trial Monitors (CRA) - UICEC

REF: 24-128_SS_PH

About the research group

Clinical Research and Clinical Trial Unit (UICEC IDIBELL) is an IDIBELL platform that gives support to the clinical research groups to conduct clinical studies without any commercial interest. UICEC activities respond to the responsibilities of researches as promoter of clinical trials (CT).

UICEC IDIBELL is part of the SCREN, a ISCIII Clinical Research Support Platform (PT20/00008)

About the role

Clinical trial monitoring: verify the compliance of the Good Clinical Practice (GCP) and the protocol research. Cooperate with the rest of activities on clinical trials documentation, archive and follow up.

Job requirements

Professional experience

• Previous experience in clinical trial (CT) monitoring
• Previous experience in monitoring drug CT and devices CTEducation and training

Education and training

• Average degree in health sciences (Medicine, Pharmacy, Biology, Biotechnology)
• Training in clinical trials monitoring and completed practices

Technical & soft skills

• Knowledge on clinical trials ethical and legal regulation
• Knowledge on Good Clinical Practice

Languages

• Good command of the English language

We will value, but not required

• National Health System knowledge/experience
• Global professional experience and academic training
• High English level
• Communication skills and teamwork
• Motivation, initiative and learning ability

What do we offer

•  No. of positions: 1
•  Estimated start date: 11/11/2024
•  Contract duration: Replacement positión
•  Estimated annual gross salary: 26.380 €
•  You will be part of a multicultural team. We have a fun loving and friendly international work environment.
•  Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
•  Possibility to work some days in remote -Teleworking
•  26 working days of holiday per year
•  System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
•  Paid leave package
•  Benefits of constant training are offered
•  We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by 18/11/2024

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

The present contract is co-financed by the Carlos III Health Institute, with file code PT20/0008, pursuant to the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. dated December 11, 2020, grants for the Units of the ISCIII Platforms supporting R&D&I in Biomedicine and Health Sciences within the Strategic Action in Health 2017-2020, and by the European Social Fund (Programming Period 2014-2020) "The ESF invests in your future.